Amwell AI Market Strategy Report - Online Doctors
This report supports CiteWorks Studio's examination of how AI search is recommending Online Doctors. For more detail, you can also read Online Doctors: AI Discovery Index.
On this report
Key Takeaways
- Amwell appears in 21.2% of AI observations in online doctors but earns valid recommendations in only 6.8%, showing a clear conversion gap from mentions to shortlist placement.
- ChatGPT is Amwell’s strongest platform, with a 15.5% valid recommendation rate and a 0.78 sentiment score, while Gemini and Google AI Mode lag well behind.
- The decision-stage pricing cluster is Amwell’s biggest value opportunity, with $56,625 in modeled AI Authority Value, but PlushCare and Sesame win more recommendation credit there.
- Amwell’s overall sentiment score of 0.45 is among the strongest in the category, suggesting the main issue is not brand perception but weak source-layer signals for recommendation ranking.
Answer Capsule
Amwell appears in 21.2% of all AI observations in the Online Doctors category but earns valid recommendations in only 6.8% of them. The benchmark shows a clear gap between visibility and recommendation power. Amwell's strongest platform is ChatGPT, where it achieves a 15.5% recommendation rate, but it underperforms substantially on Gemini and Google AI Mode. The clearest opportunity lies in converting existing mention presence into recommendation credit, particularly in the decision-stage pricing cluster where Amwell captures $56,625 in modeled AI Authority Value but is displaced by PlushCare and Sesame.
Who This Report Is For
This report is for Amwell's marketing, brand strategy, and digital health leadership teams evaluating AI recommendation-stage visibility and competitive positioning in the online doctor market.
Report Card
- Report type: AI Company Market Strategy Report
- Target company: Amwell
- Category / market studied: Online Doctors
- Reporting month: June 2026
- AI platforms tracked: ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, Google AI Overviews
- Public high-intent clusters: 3 (Consideration, Evaluation, Decision)
- AI observations analyzed: 829
- Competitors tracked: 9 (Teladoc, Doctor on Demand, HealthTap, K Health, Lemonaid Health, LiveHealth Online, MDLive, PlushCare, Sesame)
Executive Summary
Amwell appears in 176 of 829 total observations across the Online Doctors category, giving it a raw mention presence rate of 21.2%. This places Amwell among the most visible brands in the category by mention frequency. However, the benchmark reveals a significant gap between presence and recommendation power. Amwell earns valid recommendations in only 56 observations, a valid recommendation coverage rate of 6.8%. Its Top 3 recommendation rate is 4.5%, and its Rank 1 rate is just 1.1%.
The gap between mention presence and recommendation conversion is the central finding for Amwell. The brand is being listed in AI responses but is not being advanced as a top choice. This pattern is most visible on Google AI Mode, where Amwell appears in 13.8% of responses but earns valid recommendations in only 1.0% of them. On Gemini, Amwell appears in 16.0% of observations but earns valid recommendations in 5.1%.
Amwell's strongest platform is ChatGPT, where it achieves a 15.5% valid recommendation rate and a net sentiment score of 0.78. This indicates that when Amwell is recommended on ChatGPT, the framing is strongly positive. However, ChatGPT accounts for only 84 of 829 total observations, which limits the overall impact of that platform signal on Amwell's category standing.
Amwell's total monthly modeled AI Authority Value is $155,703, placing it fifth in the category behind PlushCare ($844,165), Sesame ($535,802), Doctor on Demand ($198,752), and Teladoc ($151,808 is not exceeded, noting Amwell at $155,703 ranks above Teladoc here based on the figures supplied). The modeled benchmark value is heavily concentrated at the top, with PlushCare and Sesame capturing approximately 70% of total category value. This concentration reflects how recommendation-stage visibility compounds when a brand earns consistent Top 3 placement across multiple platforms and clusters.
Amwell's net sentiment score of 0.45 across all observations is the second highest in the category behind Doctor on Demand at 0.50. This indicates that when Amwell is mentioned, the framing is more positive than most competitors, including PlushCare (0.41) and Sesame (0.42). The positive framing is a real asset. The problem is that positive framing is not translating into recommendation credit at the decision stage, where the highest-value prompts are concentrated.
What Amwell Is Winning
Amwell's strongest platform signal is on ChatGPT, where it achieves a 15.5% valid recommendation rate and a net sentiment score of 0.78. This is the highest net sentiment score Amwell achieves on any platform and indicates that when ChatGPT recommends Amwell, the framing is predominantly positive rather than cautionary or comparative-anchor.
In the decision-stage pricing cluster, Amwell captures $56,625 in modeled AI Authority Value, its strongest single-cluster performance. This cluster carries the highest buyer stage multiplier at 1.5, meaning patients engaging with pricing and cost prompts are closer to making a selection than those in consideration or evaluation stages. Amwell's $56,625 in this cluster is competitive with Sesame's $107,218 and significantly ahead of Teladoc's $8,725 in the same cluster.
Amwell's net sentiment score of 0.45 across all observations ranks second in the category. When the brand is mentioned, the framing is more positive than the category average, which is a meaningful baseline advantage. Positive framing quality is a necessary condition for recommendation conversion, even if it is not sufficient on its own.
On Google AI Overviews, Amwell achieves a sentiment score of 0.84 across 19 observations, its highest score on any platform. While the sample is small, the framing quality is notably strong and may indicate that the content AI Overviews draws from for Amwell is well-structured and authoritative.
Where Amwell Has the Clearest AI Visibility Gaps
The most significant gap is between mention presence and recommendation conversion. Amwell appears in 21.2% of observations but earns valid recommendations in only 6.8%. This means Amwell is being listed in AI responses but is not being advanced as a top choice. For comparison, PlushCare appears in 52.6% of observations and earns valid recommendations in 18.6%. Doctor on Demand appears in only 15.3% of observations but earns valid recommendations in 7.5%, a higher conversion rate than Amwell despite lower raw presence.
On Google AI Mode, the gap is most pronounced. Amwell appears in 13.8% of responses but earns valid recommendations in only 1.0%. Its Top 3 rate on this platform is 0.5%, and its Rank 1 rate is 0.0%. Patients using Google AI Mode to search for online doctors see Amwell listed but almost never see it recommended in a top position. This is the highest-risk platform gap in the dataset.
On Gemini, Amwell appears in 16.0% of observations but earns valid recommendations in only 5.1%. Its Top 3 rate is 2.9%, and its Rank 1 rate is 0.6%. PlushCare, by comparison, achieves a 25.7% valid recommendation rate on Gemini with an 11.4% Rank 1 rate. The distance between Amwell and the category leader on this platform is substantial and points to a source-layer gap rather than a brand-awareness gap.
Amwell's Top 3 rate of 4.5% across all platforms sits below the conversion rate of Doctor on Demand (5.6%) despite Amwell having higher raw mention presence. This suggests Amwell's citations and framing in the AI source layer are not structured to trigger recommendation credit even when the brand is recognized and referenced.
Biggest Opportunity
The clearest opportunity for Amwell is converting its existing mention presence into recommendation credit on Google AI Mode and Gemini. These two platforms account for a combined 371 of 829 total observations, making them the highest-volume discovery surfaces in the dataset. Amwell's valid recommendation coverage on both platforms sits below 6%, despite meaningful mention presence on each. Strengthening the source-layer evidence that AI systems draw from on these platforms, including structured pricing content, comparison-ready information, and positively framed third-party coverage, represents the highest-leverage path to improving recommendation-stage visibility without requiring a fundamental change in overall brand presence.
Prompt Evidence
ChatGPT / Consideration Prompt: "What are the best telehealth platforms?" Result: Amwell was mentioned with positive framing but was not ranked in the top three positions, representing a typical mention-without-recommendation-credit pattern on this cluster.
Gemini / Evaluation Prompt: "Compare telehealth platforms for primary care" Result: Amwell was listed as an option but PlushCare and Sesame were recommended ahead of it, with Amwell functioning as a secondary reference rather than a shortlist selection.
Google AI Mode / Decision Prompt: "How much does an online doctor visit cost?" Result: Amwell appeared in the response but was not recommended in the top three, earning zero Top 3 recommendation credit on this platform despite the decision-stage cluster carrying the highest buyer stage multiplier in the dataset.
Perplexity / Evaluation Prompt: "What are the alternatives to Teladoc?" Result: Amwell was recommended with a Rank 1 position, contributing to its 16.0% valid recommendation rate on Perplexity and demonstrating that the brand's source-layer evidence is stronger on this platform than on Google AI Mode or Gemini.
What CiteWorks Studio Would Do Next
Phase 1: AI Market Discovery Audit Map Amwell's full recommendation footprint across all six platforms and identify the specific prompts where Amwell is mentioned but not advanced to a recommendation position.
Phase 2: Recommendation Readiness Plan Prioritize Google AI Mode and Gemini for source-layer improvement, focusing on the prompts where Amwell has the widest gap between mention presence and recommendation credit.
Phase 3: Owned Answer Layer Buildout Develop structured pricing and comparison content that AI systems can retrieve and synthesize into recommendations, particularly for the decision-stage pricing cluster where Amwell's modeled value is currently being captured by PlushCare and Sesame.
Phase 4: Citation / Authority Layer Development Strengthen Amwell's presence in authoritative comparison articles, review platforms, and editorial sources that AI systems use as source material when forming recommendations at the evaluation and decision stages.
Phase 5: Monthly AI Visibility and Recommendation Tracking Monitor Amwell's valid recommendation coverage, Top 3 rate, and Rank 1 rate across platforms on a monthly basis to measure whether source-layer improvements are translating into recommendation-stage gains.
Why This Matters
Patients searching for online doctors are increasingly receiving AI-generated shortlists rather than traditional search results. These AI responses act as de facto recommendation engines, compressing the consideration set to three to five brands per query. A brand that appears in a response but is not recommended in the top three is effectively invisible to the patient making a selection. Mention presence without recommendation credit is not a competitive position.
Amwell's current position shows strong brand awareness in AI responses but weak recommendation conversion. The brands leading this category, PlushCare and Sesame, share common characteristics: strong owned content, extensive comparison and review coverage, clear pricing information, and source-layer evidence that AI systems consistently use to justify top-placement decisions. Amwell's next move is to strengthen the specific source-layer signals that AI systems use to advance a brand from listed to recommended, particularly on the two highest-volume platforms where the recommendation gap is widest.
Core Metrics
- Mentions: 176
- Valid recommendations: 56
- Top 3 recommendation count: 37
- Rank 1 recommendation count: 9
- Average recommended rank: 2.80
- Positive mentions: 81
- Neutral mentions: 94
- Negative mentions: 1
- Raw mention presence rate: 21.2%
- Valid recommendation coverage: 6.8%
- Top 3 recommendation rate: 4.5%
- Rank 1 recommendation rate: 1.1%
- Strongest cluster by recommendation behavior: Decision (Telehealth Pricing, Cost and Plans)
- Strongest platform by recommendation behavior: ChatGPT
Sentiment Score
Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions
Amwell's Sentiment Score = (81 x 1 + 94 x 0 + 1 x -1) / 176 = 80 / 176 = 0.45
This score matters because unclassified mention counts are misleading. A raw mention total does not distinguish between a positive recommendation, a neutral contextual reference, a cautionary mention, and a competitor-displaced listing. Counting all four as equivalent visibility is bad measurement. Share of voice is a diagnostic metric, not a business KPI.
Amwell's 0.45 score indicates that when the brand appears in AI responses, the framing is predominantly positive. That is a real and meaningful baseline. The problem the benchmark identifies is that positive framing quality is not translating into recommendation credit, particularly on the platforms and clusters where buyer intent is highest. Classified sentiment is the starting point for understanding that gap, not the endpoint.
Sentiment by Platform
Platform | Mentions | Positive | Neutral | Negative | Sentiment Score | Readout |
|---|---|---|---|---|---|---|
ChatGPT | 36 | 29 | 6 | 1 | 0.78 | Strongest public recommendation signal |
Copilot | 56 | 19 | 37 | 0 | 0.34 | Present, but not recommendation-led |
Gemini | 28 | 9 | 19 | 0 | 0.32 | Present, but not recommendation-led |
Google AI Mode | 27 | 2 | 25 | 0 | 0.07 | Present as context, not recommendation |
Google AI Overviews | 19 | 16 | 3 | 0 | 0.84 | Positive, but sample too small |
Perplexity | 10 | 6 | 4 | 0 | 0.60 | Positive, but sample too small |
Methodology
- This report is based on the June 2026 LLM Authority Index benchmark for the Online Doctors category, interpreted by CiteWorks Studio. It is benchmark-based analysis, not a client engagement or implementation case study.
- The reporting window is June 2026, with a snapshot date of June 16, 2026.
- Six AI platforms were tested: ChatGPT, Gemini, Copilot, Perplexity, Google AI Mode, and Google AI Overviews.
- A total of 829 observations were analyzed across three public high-intent clusters. The full benchmark includes 10 prompt clusters; this public version covers 3.
- The competitor universe includes 10 brands: Amwell, Doctor on Demand, HealthTap, K Health, Lemonaid Health, LiveHealth Online, MDLive, PlushCare, Sesame, and Teladoc.
- Three public high-intent clusters were used: Consideration (Best Telehealth Platforms and Top Virtual Care Services), Evaluation (Telehealth Platform Comparisons and Alternatives), and Decision (Telehealth Pricing, Cost and Plans).
- Stage 0 refers to the raw extraction of AI-generated responses before sentiment classification, rank assignment, or value modeling is applied.
- A mention is defined as any appearance of a company in an AI-generated response, regardless of sentiment, framing, or recommendation rank.
- A valid recommendation is a positive, shortlist-quality mention or ranked recommendation that earns recommendation credit. Neutral references, cautionary mentions, and competitor-displaced appearances are not counted as valid recommendations.
- Modeled AI Authority Value is a benchmark estimate calculated from recommendation frequency, rank position, cluster volume, and buyer stage multiplier. It is not revenue, pipeline, or booked demand.
- Sentiment score is calculated as (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions. It reflects framing quality in AI-generated responses, not customer satisfaction.
- This is a point-in-time benchmark. AI outputs are dynamic and can change between reporting periods. This report does not constitute a full audit or complete market census.
See How AI Is Recommending Your Brand
The benchmark shows which brands are winning AI recommendations in the Online Doctors category and where the recommendation gaps are widest. CiteWorks Studio maps exactly where your brand appears, where competitors are being recommended instead, which prompts carry the most commercial risk, and what changes to the source and citation layer are most likely to improve your position in AI-generated shortlists. If Amwell's recommendation gap is a question your team is ready to answer, a discovery conversation is the right next step.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


